» Articles » PMID: 33486300

A Quantitative Hematopoietic Stem Cell Reconstitution Protocol: Accounting for Recipient Variability, Tissue Distribution and Cell Half-lives

Overview
Journal Stem Cell Res
Publisher Elsevier
Specialty Cell Biology
Date 2021 Jan 24
PMID 33486300
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem and progenitor cell (HSPC) transplantation is the paradigm for stem cell therapies. The protocol described here enables quantitative assessment of the body-wide HSPC reconstitution of different mature hematopoietic cells in mice based on their presence in circulating blood. The method determines donor-derived mature cell populations per mouse, over time, by quantitatively obtaining their absolute numbers in the peripheral blood and utilizing previously assessed tissue-distribution factors. A Markov-based birth/death computational model accounts for the drastic differences in mature cell half-lives. By quantifying the number of cells produced and eliminating host variability, the protocol can be used to directly compare the lineage output of different types of HSPCs on a per cell basis, thereby clarifying the lineage potential and expansion capacity of different cell populations. These protocols were developed for hematopoiesis, but can readily be extended to other contexts by simply replacing the cell types and distributions.

Citing Articles

New transgenic mouse models enabling pan-hematopoietic or selective hematopoietic stem cell depletion in vivo.

Rodriguez Y Baena A, Rajendiran S, Manso B, Krietsch J, Boyer S, Kirschmann J Sci Rep. 2022; 12(1):3156.

PMID: 35210475 PMC: 8873235. DOI: 10.1038/s41598-022-07041-6.


IL7Rα, but not Flk2, is required for hematopoietic stem cell reconstitution of tissue-resident lymphoid cells.

Worthington A, Cool T, Poscablo D, Hussaini A, Beaudin A, Forsberg E Development. 2022; 149(8).

PMID: 35072209 PMC: 8917444. DOI: 10.1242/dev.200139.


Megakaryocyte progenitor cell function is enhanced upon aging despite the functional decline of aged hematopoietic stem cells.

Poscablo D, Worthington A, Smith-Berdan S, Forsberg E Stem Cell Reports. 2021; 16(6):1598-1613.

PMID: 34019813 PMC: 8190594. DOI: 10.1016/j.stemcr.2021.04.016.

References
1.
Cool T, Worthington A, Poscablo D, Hussaini A, Forsberg E . Interleukin 7 receptor is required for myeloid cell homeostasis and reconstitution by hematopoietic stem cells. Exp Hematol. 2020; 90:39-45.e3. PMC: 7951140. DOI: 10.1016/j.exphem.2020.09.001. View

2.
Bair S, Brandstadter J, Ayers E, Stadtmauer E . Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy. Cancer. 2020; 126(9):1837-1855. DOI: 10.1002/cncr.32659. View

3.
Jenq R, van den Brink M . Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat Rev Cancer. 2010; 10(3):213-21. DOI: 10.1038/nrc2804. View

4.
Simon S, Kim M . A day (or 5) in a neutrophil's life. Blood. 2010; 116(4):511-2. DOI: 10.1182/blood-2010-05-283184. View

5.
Khan F, Agarwal A, Agrawal S . Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant. 2004; 34(1):1-12. DOI: 10.1038/sj.bmt.1704525. View